Education
About Us
Working with TipRanks
Follow Us
Quidelortho Corporation (QDEL)
:QDEL
QDEL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$29.74 - $49.45
Previous CloseN/A
Volume114.08K
Average Volume (3M)885.53K
Market Cap
$2.36B
Enterprise Value$5.68B
Total Cash (Recent Filing)$98.30M
Total Debt (Recent Filing)$509.00M
Price to Earnings (P/E)―
Beta0.97
Next Earnings
Apr 30, 2025EPS Estimate
0.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-30.28
Shares Outstanding67,446,540
10 Day Avg. Volume969,836
30 Day Avg. Volume885,532
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.87
Price to Cash Flow (P/CF)9.50
P/FCF Ratio5.30
Enterprise Value/Market Cap2.40
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.41
Enterprise Value/Ebitda-3.47
Forecast
1Y Price Target
$60.33Price Target Upside72.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
QuidelOrtho News
PremiumCompany Announcements
QuidelOrtho’s Earnings Call: Mixed Sentiment Amidst Revenue Decline
PremiumCompany Announcements
QuidelOrtho Reports 2024 Results and 2025 Outlook
---
Ownership Overview
1.38% Insiders
30.85% Mutual Funds
0.22% Other Institutional Investors
37.74% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
QDEL FAQ
What was Quidelortho Corporation’s price range in the past 12 months?
Quidelortho Corporation lowest stock price was $29.73 and its highest was $49.45 in the past 12 months.
What is Quidelortho Corporation’s market cap?
Quidelortho Corporation’s market cap is $2.36B.
When is Quidelortho Corporation’s upcoming earnings report date?
Quidelortho Corporation’s upcoming earnings report date is Apr 30, 2025 which is in 33 days.
How were Quidelortho Corporation’s earnings last quarter?
Quidelortho Corporation released its earnings results on Feb 12, 2025. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.591 by $0.039.
Is Quidelortho Corporation overvalued?
According to Wall Street analysts Quidelortho Corporation’s price is currently Undervalued.
Does Quidelortho Corporation pay dividends?
Quidelortho Corporation does not currently pay dividends.
What is Quidelortho Corporation’s EPS estimate?
Quidelortho Corporation’s EPS estimate is 0.61.
How many shares outstanding does Quidelortho Corporation have?
Quidelortho Corporation has 67,446,540 shares outstanding.
What happened to Quidelortho Corporation’s price movement after its last earnings report?
Quidelortho Corporation reported an EPS of $0.63 in its last earnings report, beating expectations of $0.591. Following the earnings report the stock price went up 4.281%.
Which hedge fund is a major shareholder of Quidelortho Corporation?
Currently, no hedge funds are holding shares in QDEL
---
QuidelOrtho Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$60.33 (72.27% Upside)
$60.33 (72.27% Upside)
Blogger Sentiment
Bullish
QDEL Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 857.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $249.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 6.9%
Last 30 Days ▼ 6.9%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.48%
12-Months-Change
Fundamentals
Return on Equity
-50.74%
Trailing 12-Months
Asset Growth
-18.63%
Trailing 12-Months
Company Description
Quidelortho Corporation
QuidelOrtho Corporation (QDEL) is a prominent player in the healthcare sector, specializing in the development, manufacturing, and distribution of diagnostic testing solutions. The company operates in the in vitro diagnostics (IVD) industry, providing innovative diagnostic products and services that aid in disease detection and management. QuidelOrtho's core offerings include immunoassays, molecular diagnostic tests, point-of-care testing solutions, and clinical chemistry and blood bank reagents, serving a diverse range of customers worldwide, including hospitals, laboratories, and physician offices.
---
QDEL Company Deck
---
QDEL Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed sentiment. While there are significant operational highlights such as growth in the labs business, cost reduction initiatives, and stable performance in key markets like China, challenges persist with a decrease in total revenue, particularly in North America and cardiac products. The company is focused on cost savings and margin expansion, pointing to a strategic direction towards profitability amidst declining revenues in certain sectors.Read More>---
QDEL Stock 12 Month Forecast
Average Price Target
$60.33
▲(72.27% Upside)
Technical Analysis
Best Analysts Covering QDEL
1 Year
1 Year Success Rate
0/14 ratings generated profit
1 Year Average Return
-25.41%
reiterated a buy rating last month
Copying Andrew Cooper's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -25.41% per trade.
---